The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Autoimmune Therapeutics Drugs Market Research Report 2025
Synopsis
The global Autoimmune Therapeutics Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Therapeutics Drugs.
Report Scope
The Autoimmune Therapeutics Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autoimmune Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Therapeutics Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Amgen
Novartis
Eli Lilly and Company
Pfizer
Roche Holding AG
AstraZeneca
Abbott Laboratories
Genentech
Merck & Co.
Bayer
Biogen
GlaxoSmithKline
Perrigo
Segment by Type
NSAIDs
Corticosteroids
Disease-Modifying Anti-Rheumatic Drugs
Monoclonal Antibodies
Segment by Application
Hospitals and Clinics
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Therapeutics Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Autoimmune Therapeutics Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Therapeutics Drugs.
Report Scope
The Autoimmune Therapeutics Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autoimmune Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Therapeutics Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Amgen
Novartis
Eli Lilly and Company
Pfizer
Roche Holding AG
AstraZeneca
Abbott Laboratories
Genentech
Merck & Co.
Bayer
Biogen
GlaxoSmithKline
Perrigo
Segment by Type
NSAIDs
Corticosteroids
Disease-Modifying Anti-Rheumatic Drugs
Monoclonal Antibodies
Segment by Application
Hospitals and Clinics
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Therapeutics Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Therapeutics Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NSAIDs
1.2.3 Corticosteroids
1.2.4 Disease-Modifying Anti-Rheumatic Drugs
1.2.5 Monoclonal Antibodies
1.3 Market by Application
1.3.1 Global Autoimmune Therapeutics Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Therapeutics Drugs Market Perspective (2019-2030)
2.2 Autoimmune Therapeutics Drugs Growth Trends by Region
2.2.1 Global Autoimmune Therapeutics Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Autoimmune Therapeutics Drugs Historic Market Size by Region (2019-2024)
2.2.3 Autoimmune Therapeutics Drugs Forecasted Market Size by Region (2025-2030)
2.3 Autoimmune Therapeutics Drugs Market Dynamics
2.3.1 Autoimmune Therapeutics Drugs Industry Trends
2.3.2 Autoimmune Therapeutics Drugs Market Drivers
2.3.3 Autoimmune Therapeutics Drugs Market Challenges
2.3.4 Autoimmune Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Therapeutics Drugs Players by Revenue
3.1.1 Global Top Autoimmune Therapeutics Drugs Players by Revenue (2019-2024)
3.1.2 Global Autoimmune Therapeutics Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Autoimmune Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Therapeutics Drugs Revenue
3.4 Global Autoimmune Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Autoimmune Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Therapeutics Drugs Revenue in 2023
3.5 Autoimmune Therapeutics Drugs Key Players Head office and Area Served
3.6 Key Players Autoimmune Therapeutics Drugs Product Solution and Service
3.7 Date of Enter into Autoimmune Therapeutics Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Therapeutics Drugs Breakdown Data by Type
4.1 Global Autoimmune Therapeutics Drugs Historic Market Size by Type (2019-2024)
4.2 Global Autoimmune Therapeutics Drugs Forecasted Market Size by Type (2025-2030)
5 Autoimmune Therapeutics Drugs Breakdown Data by Application
5.1 Global Autoimmune Therapeutics Drugs Historic Market Size by Application (2019-2024)
5.2 Global Autoimmune Therapeutics Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Autoimmune Therapeutics Drugs Market Size (2019-2030)
6.2 North America Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Autoimmune Therapeutics Drugs Market Size by Country (2019-2024)
6.4 North America Autoimmune Therapeutics Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autoimmune Therapeutics Drugs Market Size (2019-2030)
7.2 Europe Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Autoimmune Therapeutics Drugs Market Size by Country (2019-2024)
7.4 Europe Autoimmune Therapeutics Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Therapeutics Drugs Market Size (2019-2030)
8.2 Asia-Pacific Autoimmune Therapeutics Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autoimmune Therapeutics Drugs Market Size (2019-2030)
9.2 Latin America Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Autoimmune Therapeutics Drugs Market Size by Country (2019-2024)
9.4 Latin America Autoimmune Therapeutics Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Therapeutics Drugs Market Size (2019-2030)
10.2 Middle East & Africa Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Autoimmune Therapeutics Drugs Introduction
11.1.4 AbbVie Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Autoimmune Therapeutics Drugs Introduction
11.2.4 Amgen Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Autoimmune Therapeutics Drugs Introduction
11.3.4 Novartis Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Detail
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Autoimmune Therapeutics Drugs Introduction
11.4.4 Eli Lilly and Company Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.4.5 Eli Lilly and Company Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Autoimmune Therapeutics Drugs Introduction
11.5.4 Pfizer Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Roche Holding AG
11.6.1 Roche Holding AG Company Detail
11.6.2 Roche Holding AG Business Overview
11.6.3 Roche Holding AG Autoimmune Therapeutics Drugs Introduction
11.6.4 Roche Holding AG Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.6.5 Roche Holding AG Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Autoimmune Therapeutics Drugs Introduction
11.7.4 AstraZeneca Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Detail
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Autoimmune Therapeutics Drugs Introduction
11.8.4 Abbott Laboratories Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.8.5 Abbott Laboratories Recent Development
11.9 Genentech
11.9.1 Genentech Company Detail
11.9.2 Genentech Business Overview
11.9.3 Genentech Autoimmune Therapeutics Drugs Introduction
11.9.4 Genentech Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.9.5 Genentech Recent Development
11.10 Merck & Co.
11.10.1 Merck & Co. Company Detail
11.10.2 Merck & Co. Business Overview
11.10.3 Merck & Co. Autoimmune Therapeutics Drugs Introduction
11.10.4 Merck & Co. Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.10.5 Merck & Co. Recent Development
11.11 Bayer
11.11.1 Bayer Company Detail
11.11.2 Bayer Business Overview
11.11.3 Bayer Autoimmune Therapeutics Drugs Introduction
11.11.4 Bayer Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.11.5 Bayer Recent Development
11.12 Biogen
11.12.1 Biogen Company Detail
11.12.2 Biogen Business Overview
11.12.3 Biogen Autoimmune Therapeutics Drugs Introduction
11.12.4 Biogen Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.12.5 Biogen Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Detail
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Autoimmune Therapeutics Drugs Introduction
11.13.4 GlaxoSmithKline Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.13.5 GlaxoSmithKline Recent Development
11.14 Perrigo
11.14.1 Perrigo Company Detail
11.14.2 Perrigo Business Overview
11.14.3 Perrigo Autoimmune Therapeutics Drugs Introduction
11.14.4 Perrigo Revenue in Autoimmune Therapeutics Drugs Business (2019-2024)
11.14.5 Perrigo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Autoimmune Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of NSAIDs
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Disease-Modifying Anti-Rheumatic Drugs
Table 5. Key Players of Monoclonal Antibodies
Table 6. Global Autoimmune Therapeutics Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Autoimmune Therapeutics Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Autoimmune Therapeutics Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Autoimmune Therapeutics Drugs Market Share by Region (2019-2024)
Table 10. Global Autoimmune Therapeutics Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Autoimmune Therapeutics Drugs Market Share by Region (2025-2030)
Table 12. Autoimmune Therapeutics Drugs Market Trends
Table 13. Autoimmune Therapeutics Drugs Market Drivers
Table 14. Autoimmune Therapeutics Drugs Market Challenges
Table 15. Autoimmune Therapeutics Drugs Market Restraints
Table 16. Global Autoimmune Therapeutics Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Autoimmune Therapeutics Drugs Market Share by Players (2019-2024)
Table 18. Global Top Autoimmune Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Therapeutics Drugs as of 2023)
Table 19. Ranking of Global Top Autoimmune Therapeutics Drugs Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Autoimmune Therapeutics Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Autoimmune Therapeutics Drugs Product Solution and Service
Table 23. Date of Enter into Autoimmune Therapeutics Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Autoimmune Therapeutics Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Autoimmune Therapeutics Drugs Revenue Market Share by Type (2019-2024)
Table 27. Global Autoimmune Therapeutics Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Autoimmune Therapeutics Drugs Revenue Market Share by Type (2025-2030)
Table 29. Global Autoimmune Therapeutics Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Autoimmune Therapeutics Drugs Revenue Market Share by Application (2019-2024)
Table 31. Global Autoimmune Therapeutics Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Autoimmune Therapeutics Drugs Revenue Market Share by Application (2025-2030)
Table 33. North America Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Autoimmune Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Autoimmune Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Autoimmune Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Autoimmune Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Autoimmune Therapeutics Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Autoimmune Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Autoimmune Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. AbbVie Company Detail
Table 49. AbbVie Business Overview
Table 50. AbbVie Autoimmune Therapeutics Drugs Product
Table 51. AbbVie Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 52. AbbVie Recent Development
Table 53. Amgen Company Detail
Table 54. Amgen Business Overview
Table 55. Amgen Autoimmune Therapeutics Drugs Product
Table 56. Amgen Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 57. Amgen Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis Autoimmune Therapeutics Drugs Product
Table 61. Novartis Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Eli Lilly and Company Company Detail
Table 64. Eli Lilly and Company Business Overview
Table 65. Eli Lilly and Company Autoimmune Therapeutics Drugs Product
Table 66. Eli Lilly and Company Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 67. Eli Lilly and Company Recent Development
Table 68. Pfizer Company Detail
Table 69. Pfizer Business Overview
Table 70. Pfizer Autoimmune Therapeutics Drugs Product
Table 71. Pfizer Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Roche Holding AG Company Detail
Table 74. Roche Holding AG Business Overview
Table 75. Roche Holding AG Autoimmune Therapeutics Drugs Product
Table 76. Roche Holding AG Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 77. Roche Holding AG Recent Development
Table 78. AstraZeneca Company Detail
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Autoimmune Therapeutics Drugs Product
Table 81. AstraZeneca Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Abbott Laboratories Company Detail
Table 84. Abbott Laboratories Business Overview
Table 85. Abbott Laboratories Autoimmune Therapeutics Drugs Product
Table 86. Abbott Laboratories Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 87. Abbott Laboratories Recent Development
Table 88. Genentech Company Detail
Table 89. Genentech Business Overview
Table 90. Genentech Autoimmune Therapeutics Drugs Product
Table 91. Genentech Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 92. Genentech Recent Development
Table 93. Merck & Co. Company Detail
Table 94. Merck & Co. Business Overview
Table 95. Merck & Co. Autoimmune Therapeutics Drugs Product
Table 96. Merck & Co. Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 97. Merck & Co. Recent Development
Table 98. Bayer Company Detail
Table 99. Bayer Business Overview
Table 100. Bayer Autoimmune Therapeutics Drugs Product
Table 101. Bayer Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 102. Bayer Recent Development
Table 103. Biogen Company Detail
Table 104. Biogen Business Overview
Table 105. Biogen Autoimmune Therapeutics Drugs Product
Table 106. Biogen Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 107. Biogen Recent Development
Table 108. GlaxoSmithKline Company Detail
Table 109. GlaxoSmithKline Business Overview
Table 110. GlaxoSmithKline Autoimmune Therapeutics Drugs Product
Table 111. GlaxoSmithKline Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 112. GlaxoSmithKline Recent Development
Table 113. Perrigo Company Detail
Table 114. Perrigo Business Overview
Table 115. Perrigo Autoimmune Therapeutics Drugs Product
Table 116. Perrigo Revenue in Autoimmune Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 117. Perrigo Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Therapeutics Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Autoimmune Therapeutics Drugs Market Share by Type: 2023 VS 2030
Figure 3. NSAIDs Features
Figure 4. Corticosteroids Features
Figure 5. Disease-Modifying Anti-Rheumatic Drugs Features
Figure 6. Monoclonal Antibodies Features
Figure 7. Global Autoimmune Therapeutics Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Autoimmune Therapeutics Drugs Market Share by Application: 2023 VS 2030
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Autoimmune Therapeutics Drugs Report Years Considered
Figure 13. Global Autoimmune Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Autoimmune Therapeutics Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Autoimmune Therapeutics Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Autoimmune Therapeutics Drugs Market Share by Players in 2023
Figure 17. Global Top Autoimmune Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Therapeutics Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Autoimmune Therapeutics Drugs Revenue in 2023
Figure 19. North America Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Autoimmune Therapeutics Drugs Market Share by Country (2019-2030)
Figure 21. United States Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Autoimmune Therapeutics Drugs Market Share by Country (2019-2030)
Figure 25. Germany Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Autoimmune Therapeutics Drugs Market Share by Region (2019-2030)
Figure 33. China Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Autoimmune Therapeutics Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Autoimmune Therapeutics Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Autoimmune Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. AbbVie Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 48. Amgen Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 50. Eli Lilly and Company Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 51. Pfizer Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 52. Roche Holding AG Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 53. AstraZeneca Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 54. Abbott Laboratories Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 55. Genentech Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 56. Merck & Co. Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 57. Bayer Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 58. Biogen Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 60. Perrigo Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
